Leiden University Scholarly Publications

Persistent URL of this record https://hdl.handle.net/1887/3184771

Documents

Beta release

Statistics of Phase II feasibility and biomarker study of neoadjuvant trastuzumab and pertuzumab with chemoradiotherapy for resectable human epidermal growth factor receptor 2-positive esophageal adenocarcinoma
Statistics for this year
PeriodVisitsDownloads
20241614
Statistics for the last 3 months
PeriodVisitsDownloads
2024-0800
2024-0922
2024-1011